Effect of Ensifentrine Treatment on CAT Score

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 11, 2024

Primary Completion Date

November 26, 2024

Study Completion Date

December 3, 2024

Conditions

COPD

Interventions

DRUG

Ensifentrine 3 mg twice daily

All subjects will receive ensifentrine.

Trial Locations (1)

Midwest Chest Consultants, Saint Charles

All Listed Sponsors

collaborator

Midwest Chest Consultants

OTHER

lead

Verona Pharma plc

INDUSTRY

NCT06460493 - Effect of Ensifentrine Treatment on CAT Score | Biotech Hunter | Biotech Hunter